Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» GSK wins $235 million from Teva in Coreg patent trial
GSK wins $235 million from Teva in Coreg patent trial
GSK wins $235 million from Teva in Coreg patent trial
Submitted by
admin
on June 23, 2017 - 9:43am
Source:
Reuters
News Tags:
GSK
Teva Pharmaceutical
Coreg
patents
chronic heart failure
Headline:
GSK wins $235 million from Teva in Coreg patent trial
Do Not Allow Advertisers to Use My Personal information
